Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Williams

Showing results (321-330 of 394) with videos related to

Pageof 40
Sort By:
Neuropharmacology|September 25, 2015
3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonistRobert L Hudkins, John A Gruner, Rita Raddatz, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|December 9, 2021
Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Vision Rehabilitation UtilizationSandra L Winkler, Jacob Marszalek, Xinping Wang, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2007
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthmaPatrick Flood-Page, Cheri Swenson, Isidore Faiferman, et al.
Plos Pathogens|January 5, 2011
Large-scale field application of RNAi technology reducing Israeli acute paralysis virus disease in honey bees (Apis mellifera, Hymenoptera: Apidae)Wayne Hunter, James Ellis, Dennis Vanengelsdorp, et al.
Environment International|June 22, 2019
Just the tonic! Legume biorefining for alcohol has the potential to reduce Europe's protein deficit and mitigate climate changeTheophile Lienhardt, Kirsty Black, Sophie Saget, et al.
The New Zealand Medical Journal|December 24, 2013
The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional careChris Ellis, Greg Gamble, Gerard Devlin, et al.
Nature Materials|June 15, 2021
Kirigami-inspired stents for sustained local delivery of therapeuticsSahab Babaee, Yichao Shi, Saeed Abbasalizadeh, et al.
BMJ Open|September 24, 2018
Strategies to improve the implementation of policies, practices or programmes in sporting organisations targeting poor diet, physical inactivity, obesity, risky alcohol use or tobacco use: a systematic reviewTameka McFadyen, Li Kheng Chai, Rebecca Wyse, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective propertiesArthur A Hancock, Steven A Buckner, Michael E Brune, et al.
International Journal of Molecular Sciences|October 13, 2021
Platelet Inhibition Prevents NLRP3 Inflammasome Activation and Sepsis-Induced Kidney InjuryMarivee Borges-Rodriguez, Corbin A Shields, Olivia K Travis, et al.
Pageof 40

Showing results (321-330 of 394) with videos related to

Sort By:
Pageof 40
Neuropharmacology|September 25, 2015
3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonistRobert L Hudkins, John A Gruner, Rita Raddatz, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|December 9, 2021
Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Vision Rehabilitation UtilizationSandra L Winkler, Jacob Marszalek, Xinping Wang, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2007
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthmaPatrick Flood-Page, Cheri Swenson, Isidore Faiferman, et al.
Plos Pathogens|January 5, 2011
Large-scale field application of RNAi technology reducing Israeli acute paralysis virus disease in honey bees (Apis mellifera, Hymenoptera: Apidae)Wayne Hunter, James Ellis, Dennis Vanengelsdorp, et al.
Environment International|June 22, 2019
Just the tonic! Legume biorefining for alcohol has the potential to reduce Europe's protein deficit and mitigate climate changeTheophile Lienhardt, Kirsty Black, Sophie Saget, et al.
The New Zealand Medical Journal|December 24, 2013
The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional careChris Ellis, Greg Gamble, Gerard Devlin, et al.
Nature Materials|June 15, 2021
Kirigami-inspired stents for sustained local delivery of therapeuticsSahab Babaee, Yichao Shi, Saeed Abbasalizadeh, et al.
BMJ Open|September 24, 2018
Strategies to improve the implementation of policies, practices or programmes in sporting organisations targeting poor diet, physical inactivity, obesity, risky alcohol use or tobacco use: a systematic reviewTameka McFadyen, Li Kheng Chai, Rebecca Wyse, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective propertiesArthur A Hancock, Steven A Buckner, Michael E Brune, et al.
International Journal of Molecular Sciences|October 13, 2021
Platelet Inhibition Prevents NLRP3 Inflammasome Activation and Sepsis-Induced Kidney InjuryMarivee Borges-Rodriguez, Corbin A Shields, Olivia K Travis, et al.
Pageof 40